About this trial
The aim of this study is to determine whether the diffuse cerebral metabolic disturbances observed in glioblastoma are exclusively linked to the direct and indirect effects of tumor infiltration (particularly structural disconnection), or whether they also reflect a more global alteration of neurometabolic and neurovascular coupling mechanisms.
This approach thus aims to better understand the pathophysiological basis of cognitive impairment in glioblastoma and to characterize the impact of the disease at the level of brain networks.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients
Patients with glioblastoma
Preoperative metabolic evaluation of a brain-expanding lesion
Disqualifiers
Contraindications to MRI
Minor or incapacitated adult
Patient deprived of liberty
Patient under legal guardianship
Trial design
Single group
Treatments tested in this trial
18F-FDG PET/MRI with additional DTI and rs-fMRI sequences
Other interventionfluorodeoxyglucose (Fluor18) (18F-FDG) PET/MRI with additional DTI and rs-fMRI sequences correlation with neuropsychological tests
Treatment groups
Trial outcomes
Primary outcomes
Correlation between cortical energy activity (FDG PET), axonal morphological connectivity (DTI - MRI), synchronous neuronal activity (rs-fMRI), and preoperative neuropsychological performance before surgery
Secondary outcomes
correlation between cortical energy activity (FDG PET), axonal morphological connectivity (DTI - MRI), synchronous neuronal activity (rs-fMRI), and preoperative neuropsychological performance after surgery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: